Reposted by RTTQA
Last week, the FAST-Forward Boost trial completed recruitment to the Early Side Effects Substudy with 345 patients randomised.
The study will now be transitioning to the main trial part of the study with a target of 4,830 patients.
You can read more about the trial here: www.icr.ac.uk/ff-boost
icr.ac.uk
ICR-CTSU clinical trials